SCHEMBL1629689

SCHEMBL1629689

CCc1ccccc1-n1nccc1-c1ccc(OC)cc1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 5/20 0.42
PIK3CD O00329 1/20 0.40
PIK3CB P42338 1/20 0.40
PTPN1 P18031 1/20 0.40
P2RY1 P47900 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
NOTUM Q6P988 1/20 0.39
MAPT P10636 2/20 0.39
IDH1 O75874 1/20 0.39
ADORA1 P30542 1/20 0.38
USP2 O75604 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
NPC1 O15118 2/20 0.38
NR3C2 P08235 1/20 0.38
MEN1 O00255 1/20 0.38
NFKB1 P19838 1/20 0.38
RAB9A P51151 1/20 0.38
NFKB2 Q00653 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1630386 0.87 HSP90AA1 (0.51) HSP90AA1NR3C2
SCHEMBL1629073 0.84 HSP90AA1 (0.51) HSP90AA1PTPN1NOTUMMAPTIDH1
SCHEMBL1627411 0.84 NPC1 (0.44) HSP90AA1PTPN1NOTUMMAPTIDH1
SCHEMBL1630519 0.84 HSP90AA1 (0.60) HSP90AA1PIK3CDPIK3CBPTPN1NOTUM
SCHEMBL1630413 0.82 HSP90AA1 (0.49) HSP90AA1MAPTALDH1A1NR3C2SMN1; SMN2
SCHEMBL1630476 0.81 MAPT (0.45) HSP90AA1PIK3CDMAPTALDH1A1NPC1
SCHEMBL1630238 0.81 MAPT (0.51) HSP90AA1PTPN1NOTUMMAPTIDH1
SCHEMBL1630086 0.78 NPSR1 (0.52) PTPN1NOTUMMAPTIDH1USP2
SCHEMBL1629669 0.78 MAPT (0.60) PTPN1NOTUMMAPTIDH1ALDH1A1
SCHEMBL1630156 0.78 HSP90AA1 (0.49) HSP90AA1ALDH1A1NR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP claimed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US claimed
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed
EP-1776346-A1 1,5-DIPHENYLPYRAZOLES Merck Patent GmbH (DE) 2007-04-25 EP disclosed
WO-2006018082-A1 1,5-DIPHENYLPYRAZOLES MERCK PATENT GMBH (DE) 2006-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885PIK3CD 3817/4885PIK3CB 3558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.